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Hemolysis Following Coil Embolization of a Patent 
Ductus Arteriosus 
David Shim, MD, Daniel S. Wechsler, MD, PhD, Thomas R. Lloyd, MD, and 
Robert H. Beekman 111, MD 
We describe the development of hemolysls from moderate residual shunting across a 
patent ductus arteriosus following coil embollzatlon. The fall in hemoglobin levels from 
11.6 to 6.0 gm/dl necessitated a second coil procedure which resulted in complete clo- 
sure of the residual shunting and resolution of hemolysls. Therefore, appearance of 
anemia following coil embolization of patent ductus arteriosus should be monitored 
closely; however, repeat coil embolizatlon with elimination of residual shunt will lead to 
prompt recovery of normal hernoglobin levels. Q 1996 WIIOY-LISS, Inc. 
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INTRODUCTION 
Coil embolization of patent ductus arteriosus (PDA) 
has become the treatment of choice for closure of patent 
ductus arteriosus in some institutions [ 1,2]. Complica- 
tions have been few and there are no published reports of 
hemolysis after ductus coil embolization. We report a 
case of intravascular hemoly sis after coil embolization of 
PDA . 
CASEREPORT 
A heart murmur was noted in a 4-month-old infant 
during evaluation for bronchiolitis and the patient was 
referred for cardiac evaluation. A continuous murmur 
consistent with PDA was present, but no clinical evi- 
dence of congestive heart failure was found. Echocar- 
diography confirmed the presence of a restrictive PDA 
(62-80 mm Hg pressure gradient between the aorta and 
pulmonary artery), with a dilated left atrium and ventri- 
cle secondary to volume overload. Examinations at 8 and 
14 months of age continued to suggest PDA without 
congestive heart failure. Elective coil embolization of the 
PDA was scheduled at 16 months of age. Prior to the 
procedure, the child’s hemoglobin (Hgb) was 1 1.6 gldl. 
Cardiac catheterization and coil embolization was per- 
formed as was routine at our institution [l]. The mini- 
mum ductal diameter was found to be 2.8 mm, with an 
angiographically large [ l ]  left to right shunt (Fig. 1) .  A 
0.038 in. X 8 cm X 8 mm Gianturco steel embolization 
coil (Cook Inc., Bloomington, IN) was implanted across 
the ductus, and a repeat aortogram revealed a moderate 
persistent shunt 10 minutes after placement. A second 
0.038 in. x 5 cm x 5 mm coil was implanted within the 
first coil, and a repeat aortogram revealed a small resid- 
ual shunt (Fig. 1) .  Because such residual shunts typically 
decrease or resolve with time [3], and because placement 
of additional coils might dislodge and possibly embolize 
the first two coils, no further coils were implanted. The 
patient tolerated the procedure well and was discharged 6 
h after leaving the catheterization laboratory. 
On the evening of the first post-procedure day, the 
patient’s urine appeared dark, although she was afebrile 
and otherwise asymptomatic. A urinalysis performed by 
her pediatrician the following morning revealed hemo- 
globinuria without red blood cells. Complete blood count 
revealed a decrease in Hgb to 10.2 g/dl and microcytes 
were seen on peripheral blood smear. Blood chemistries 
performed on the third day were remarkable for mark- 
edly elevated lactate dehydrogenase (5,240 IU/L; normal 
300-650) and total serum bilirubin (1.8 mg/dl; normal 
0.1-1 .O). Serial laboratory studies over the following 
week revealed continued decrease in Hgb and increase in 
reticulocyte count (Fig. 2); therefore, referral was made 
to Pediatric Hematology. On the eighth post-procedure 
day, the reticulocyte count was 1 1 %  and peripheral 
blood smear was remarkable for the presence of nucle- 
ated red blood cells and evidence of hemolysis. Serum 
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Fig. 1A and 6. 
Hemolysis Following PDA Coil Embolization 289 
" 
Fig. 1. A: Initial lateral aortogram revealing a large left-to-right 
shunt through a patent ductus arterlosus. B: After placement of 
2 Gianturco coils, a small residual shunt is seen. Note the large 
coil loops in the lumen of the pulmonary artery. C: At a repeat 
coil procedure, 3 additional coils are implanted into the ductus 
with trace residual shunt noted on the final aortogram. 
free hemoglobin was found to be elevated (38.3 mg/dl; 
normal 1-8), serum haptoglobin was markedly reduced 
(<6 mg/dl; normal 22-239), and methemalbumin was 
detected (0.14 g/dl; normal undetectable), all consistent 
with ongoing red cell breakdown. Urinalysis continued 
to reveal hemoglobinuria despite the urine appearing 
grossly clear. The platelet count was normal, and direct 
and indirect Coombs' tests were negative. Echocardio- 
graphy revealed significant residual shunting across the 
PDA . 
When the hemoglobin had dropped to 6.0 g/dl on the 
ninth post-procedure day, the patient underwent a second 
coil embolization procedure, in which a 0.038 in. X 5 
cm X 5 mm coil, a 0.038 in. X 4 cm X 3 mm coil, and 
a 0.035 in. X 4 cm X 3 mm coil were placed. Trace 
residual shunting was noted at repeat aortogram (Fig. l),  
which was still evident on echocardiogram the following 
morning. The initial increase in the Hgb noted after this 
procedure (Fig. 2) may relate partially to dehydration, 
however the patient's hemolysis resolved with a steady 
increase in the patient's Hgb with a concomitant decrease 
in the reticulocyte count and lactate dehydrogenase over 
the following 4 weeks. She received no supplemental 
iron therapy. One month following the repeat coil em- 
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Fig. 2. Graph revealing decrease in hemoglobin (HGB) level 
and increase in reticulocyte count (RETICS) following the initial 
coil embollzation procedure (day 0) and then recovery following 
a repeat coil procedure (arrow). There is also marked elevation 
of lactate dehydrogenase (LDH) initially on day 6 with steady 
decline following resolution of significant ductal shunting. 
bolization procedure, the Hgb was 1 1.5 gn-ddl, reticulo- 
cyte count was 0.676, and the lactate dehydrogenase was 
796 IU/L. Echocardiography revealed no residual ductal 
shunting. 
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DISCUSSION 
Percutaneous coil occlusion of the patent ductus arte- 
riosus has become the treatment of choice in many in- 
stitutions with few complications [2]. Hemolysis follow- 
ing transcatheter occlusion has been previously described 
after implantation of a Rashkind PDA occlusion device 
[4,5], but this phenomenon has not been reported after 
PDA occlusion with Gianturco coils. The patient de- 
scribed had clear evidence of ongoing hemolysis with a 
vigorous erythropoietic response. The development of 
anemia correlated with the presence of significant resid- 
ual shunt and began to resolve after marked reduction of 
the residual shunt following the second coil embolization 
procedure. Presumably, red blood cells were traumatized 
due to the high velocity jet of residual ductal shunting 
through the two Gianturco coils initially placed. A thor- 
ough diagnostic evaluation, and the gratifying response 
to the second (successful) coil occlusion procedure rule 
out other possible causes for this patient’s hemolytic pro- 
cess. Our experience represents the first reported case of 
significant hemolysis following coil occlusion of a patent 
ductus. Therefore, appearance of anemia in a previously 
healthy child recently treated with coil embolization of 
patent ductus arteriosus should be taken seriously, how- 
ever repeat coil embolization of residual shunts can elim- 
inate ongoing hemolysis and lead to prompt recovery of 
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